denosumab
daiichi sankyo,amgen
['denosumab']
interesting newer potential theraputics in #handoa discussed at #eular2023 - denosumab had clear structure modifying effects in erosive habd oa compared to placebo. monocentric, placebo controlled, doubke blind phase 2 study of 100 pts. abst#op0071
Rheumatologist @HSpecialSurgery @WeillCornell ClinicalResearch | Big Data | Outcomes | Epidemiology | Disparities | Table tennis player | Tweets are my own.